MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cognitive dysfunction"

  • 2024 International Congress

    New α-Synuclein Strain Biomarker in Parkinson’s Disease and Related Dementia

    K. Gadhave, R. Chen, V. Dawson, T. Dawson, L. Rosenthal, X. Mao ()

    Objective: Biomarker development for Parkinson’s disease and related dementia. Background: α-Synuclein (α-syn) strains can serve as discriminators of Parkinson's disease (PD) from other α-synucleinopathies. However,…
  • 2024 International Congress

    Cognitive function of patients with Parkinson´s Disease after Deep Brain Stimulation: a gene- and variant-based approach

    E. Asimakidou, G. Xiromerisiou, C. Sidiropoulos (Cambridge, United Kingdom)

    Objective: To investigate the cognitive outcomes of Deep Brain Stimulation (DBS) in conjunction with the genetic profile of Parkinson´s disease (PD) patients. Background: There are…
  • 2024 International Congress

    Orthostatic Hypotension is Associated with Worse Verbal Letter Fluency and Lower Neural Efficiency While Upright in Parkinson’s Disease: A Pilot Study

    K. Longardner, P. Reddy, K. Izzetoglu, I. Litvan (SAN DIEGO, USA)

    Objective: To evaluate positional effects on cognitive performance and cerebral hemodynamics in Parkinson’s disease (PD) patients with and without orthostatic hypotension (OH). Background: OH is…
  • 2024 International Congress

    Investigating Cognitive Impairments in early Parkinson’s disease

    K. Patel, K. van Hedger, S. Pasternak, P. Macdonald (London, Canada)

    Objective: We investigated cognitive performance in patients with early Parkinson’s disease (PD). Background: Cognitive impairment is a common non-motor symptom of PD, generally detected later…
  • 2024 International Congress

    State of happiness as outcome measure in sleep disorders in Parkinson’s disease

    I. Murasan, S. Diaconu, L. Ungureanu, R. Filip, L. Irincu, C. Falup-Pecurariu (Brasov, Romania)

    Objective: The objective of this study was to evaluate state of hapiness as outcome measure in sleep disorders in PD. Background: Outcome measures are very…
  • 2024 International Congress

    Use of Machine Learning for Identification of Parkinson’s Disease and Mild Cognitive Impairment through Neuroimaging and Biofluid Biomarkers: A Study from the PPMI Cohort

    A-G. Dennis, A. Strafella (Toronto, Canada)

    Objective: Since current diagnostic tests for Parkinson’s Disease (PD) and mild cognitive impairment (MCI) focus on individual biomarkers, misdiagnoses can be frequent. This research aims…
  • 2024 International Congress

    Transcranial Direct Current Stimulation and Neurofunctional Physical Therapy Improves Motor and Cognitive Symptoms in a Patient with Type 1 Spinocerebellar Ataxia – A Case Report

    C. Bedeschi, P. Junior (Barueri, Brazil)

    Objective: The aim of this research was to develop and verify the effects of a Non-Invasive Neuromodulation protocol associated with Neurofunctional Physiotherapy on motor functions,…
  • 2024 International Congress

    EEG dominant frequency as a potential biomarker of cognition in Lewy body diseases.

    R. Heo, J. Wallner, N. Mukhopadhyay, D. Krusienski, M. Barrett (Richmond, USA)

    Objective: To determine whether cognitive performance correlates with posterior dominant frequency across Lewy body diseases. Background: DLB and PDD are associated with prominent posterior slow-wave…
  • 2024 International Congress

    Spatial Memory and Processing Speed as Cornerstones in Predicting Falls in Parkinson’s Disease

    S. Anis, E. Zimmerman, E. Jansen, R. Kaya, H. Fernandez, C. Lopez-Lennon, L. Dibble, A. Rosenfeldt, J. Alberts (Cleveland, USA)

    Objective: To build a fall prediction model that includes cognitive and motor outcomes in a subset of patients with Parkinson's disease (PwPD) enrolled in the…
  • 2024 International Congress

    Cognitive Impairment in a Cohort of Patients with DBS for parkinson’s disease treatment from a multicentric Cohort in Colombia

    T. Lopez Gonzalez, S. Poveda, M. Fonseca, P. Arango, O. Rojas, G. Monsalve, J. Diez, J. Lobato, O. Bernal Pacheco (Bogota, Colombia)

    Objective: The objective of the present work is to investigate the clinical outcomes related to cognitive performance in Colombian patients with DBS treatment. Background: Parkinson's…
  • « Previous Page
  • 1
  • …
  • 20
  • 21
  • 22
  • 23
  • 24
  • …
  • 128
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley